Population Group – Page 3

ViiV Healthcare’s Multifaceted Approach to Combating HIV in Black Communities

4 months ago talkbio0Tagged Black Populations, care activity, Community, community grants, HIV Prevention, Indication of (contextual qualifier), Risk, Social stigmata, ViiV Healthcare

ViiV Healthcare, HIV prevention, Black communities, Risk to Reasons, community grants, stigma reduction, education, access to care

NFL Legend Jerome Bettis Joins CDC Foundation’s “Live to the Beat” Campaign to Tackle Heart Health in Black Community

4 months ago talkbio0Tagged beat, Bettis, Black Populations, Cardiovascular Diseases, Centers for Disease Control and Prevention (U.S.), Community, Foundations, heart health, Hypertensive disease, Jerome, NEFL gene

Jerome Bettis, CDC Foundation, Live to the Beat, cardiovascular disease, Black community, hypertension, heart health, NFL

AstraZeneca Invests $570M in Canadian Expansion, Creating 700 New Jobs

5 months ago talkbio0Tagged AstraZeneca, Canadian, Clinical Trials, Drug Industry, expansion, Investments, R&D

AstraZeneca, Canadian expansion, $570M investment, 700 new jobs, life sciences, R&D, clinical trials, pharmaceutical industry

Revitalizing Maternal Health: Nonprofit Leverages Low-Dose Aspirin to Combat Preeclampsia Disparities

5 months ago talkbio0Tagged aspirin, Black Populations, GTPase-Activating Proteins, health disparity, Health Equity, Low-Dose, Mother (person), Pre-Eclampsia, SPIRIN

Preeclampsia, Maternal Health Equity, Low-Dose Aspirin, GAP—SPIRIN, Health Disparities, Black Maternal Health

GLP-1 Medications: Balancing Efficacy and Concerns Amidst Celebrity Endorsements and Rising Demand

5 months ago talkbio0Tagged agonists, aspects of adverse effects, Diabetes Mellitus, Non-Insulin-Dependent, Employer, Endorsements, Famous Persons, Financial cost, Glucagon-Like Peptide 1, Health Planning, Long-term Safety, Weight Loss

GLP-1 agonists, Weight loss, Type 2 diabetes, Celebrity endorsements, Side effects, Long-term safety, Cost implications, Employer health plans

EU Regulator to Investigate Potential Link Between Ozempic and Rare Eye Condition NAION

6 months ago talkbio0Tagged Agencies, Diabetes, European (ethnic group), Evaluation, NAION, Nordisk, Ozempic, semaglutide

Ozempic, NAION, European Medicines Agency, Novo Nordisk, semaglutide, eye disorder, diabetes drug, investigation

European Commission Approves Novo Holdings’ $16.5B Acquisition of Catalent

6 months ago talkbio0Tagged Acquisition, Catalent, Commission, Drug Industry, European (ethnic group), Holdings

Novo Holdings, Catalent, European Commission, Acquisition, Pharmaceutical Industry

Novo Holdings Receives Unconditional EU Approval for $16.5 Billion Acquisition of Catalent

6 months ago talkbio0Tagged Acquisition, Approved, Catalent, Commission, EU, European (ethnic group), Holdings, Pharmaceutical Services

Novo Holdings, Catalent, European Commission, Acquisition, EU Approval, Pharmaceutical Services

European Commission Revokes Marketing Authorization for Ocaliva, a Liver Disease Drug, Amid Regulatory Dispute

6 months ago talkbio0Tagged Advanz Pharma, authorization, Commission, European (ethnic group), Liver diseases, Ocaliva, PBC, Primary Biliary Cholangitis

Ocaliva, European Commission, Marketing Authorization, Liver Disease, Primary Biliary Cholangitis (PBC), Advanz Pharma

European Commission Approves BeiGene’s TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer

6 months ago talkbio0Tagged BeiGene, Cancer Therapeutic Procedure, Commission approval, European (ethnic group), first-line, Gastroesophageal Junction Adenocarcinoma, Squamous cell carcinoma of esophagus, Stomach, Tevimbra, tislelizumab

TEVIMBRA, tislelizumab, European Commission approval, first-line treatment, esophageal squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, cancer treatment, BeiGene.